Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

IN THE SPOTLIGHT: ABS Grants AiP to Wison’s FLNG Design

  (SHANGHAI) ABS has granted Approval in Principal to Wison Offshore and Marine (WOM) for its standardised 1.3MTPA and 3.0MTPA floating liquefied natural gas (FLNG) designs. ABS Vice President，Global Gas Solutions，Mr. Patrick Janssens said： “ABS has been the preferred classification organization for the offshore and energy industry for more than 60 years. With increasing global concern for the environment, clean gas-based energy plays an integral role within that framework. ABS applies its experience and knowledge to support members and clients involved in gas-related

New research highlights the importance of the thymus in successful pregnancies

How the immune system adapts to pregnancies has puzzled scientists for decades. Now, findings from an international group of researchers, led by researchers at Karolinska Institutet in Sweden, reveal important changes that occur in the thymus to prevent miscarriages and gestational diabetes. The results are published in the journal Nature.The thymus is a central organ of the immune system where specialised immune cells called T lymphocytes mature. These cells, commonly referred to as T cells, then migrate into the blood stream and tissues to help combat pathogens and cancer. An important T

Summons and agenda to extraordinary general meeting in Otello Corporation ASA

Please find attached the calling notice for an extraordinary general meeting to be held on 15 January 2021 at 0900 Norwegian time. Shareholders are urged not to attend in person but to provide voting proxies.    Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com   About Otello: Otello holds shares in several different businesses, including (i) AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their businesses, capitalizing on a global consumer audience reach that exceeds 2

#20-464 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#20-463 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Cloudberry Clean Energy AS | Acqusition of 15% of Odal Vindkraftverk AS

Oslo, Norway, 23 December 2020: Reference is made to the stock exchange announcement dated 9 December 2020 regarding Cloudberry Clean Energy AS` ("Cloudberry" or the "Company") share purchase agreement for the acquisition of up to 33.4% of the shares in Odal Vindkraftverk AS (the "Odal windfarm").Cloudberry has today completed a transaction for the acquisition of 15% of Odal windfarm. Cloudberry has the right to, and intends to, acquire up to a 33.4% shareholding in Odal windfarm by 30 June 2021. “The wind farm is located in an area with strong demand for new renewable power and is expected

SBB completes acquisition of 44.2 percent of the shares and votes in Offentliga Hus and resolves on a directed issue of Class D common shares

The potential Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the potential Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law. Press release 23 December 2020 SBB completes acquisition of 44.2 percent of the shares and

Senzime granted US Patent for OnZurf Probe

Press release: Uppsala, December 23, 2020. Senzime AB (publ) today announces that the company’s Patent application has been allowed for issuance as a patent for OnZurf Probe in the US. OnZurf is a microdialysis probe designed to monitor gastro-intestinal organs such as esophagus, stomach and liver.   The OnZurf Probe was acquired by Senzime in 2016 and is based on an innovation by Dr. Pernilla Abrahamsson and clinical research at Umeå University. The development, including CE approval of OnZurf, was completed by Senzime in 2017. The probe is designed to enable continuous sampling

RayStation 10B: Brachytherapy Planning and a Speed Revolution in Proton Monte Carlo Dose Computation

RaySearch Laboratories AB (publ) has launched the latest release of its widely adopted treatment planning system. RayStation®* 10B adds support for brachytherapy planning and a new GPU Monte Carlo algorithm, which typically cuts final dose computation times to less than five seconds. In line with the company’s aim of integrating with as many treatment delivery systems as possible, the new release includes support for high-dose-rate (HDR) brachytherapy planning. RayStation 10B features automatic channel reconstruction in combination with powerful dwell-time optimization, enabling

Share buy-backs in Tethys Oil

During the period 18 – 22 December 2020, Tethys Oil AB (publ) has repurchased a total of 106,070 of its own shares. The buy-back program, which was announced on 11 December 2020, is being conducted in accordance with the EU Market Abuse Regulation No 596/2014 and the Commission Delegated Regulation No 2016/1052.Date Aggregated Weighted average Total daily daily share price per day transaction value volume (SEK) (SEK) (number of shares)18 20,538 50.75 1,042,373December2020

Nixu Corporation: Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act

Nixu Corporation, Stock exchange release on December 23, 2020 at 16.25Nixu Corporation has received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from Handelsbanken Fonder AB on December 23, 2020. According to the notification the holding of Handelsbanken Fonder AB in the Company’s shares (ISIN: FI0009008387) has decreased under 5% on December 22, 2020. Nixu has one share series and each share entitles its holder to one (1) vote. The total number of shares is 7,425,219. Total positions of Handelsbanken Fonder AB: % of % of

RaySearch Brings Data-Driven Oncology to Cancer Clinics Worldwide with RayIntelligence

RaySearch Laboratories AB (publ) announces the launch of RayIntelligence – an advanced new software system designed to enable healthcare providers to generate actionable insights from their real-world data. Data-driven oncology represents a new era in healthcare by enabling cancer clinics to collect, structure and analyze data, for improved decision making. RayIntelligence is the latest addition to a growing portfolio of advanced software solutions from RaySearch. The aim is to empower cancer clinics to reach new levels of personalization in the care they provide using insights

Moberg Pharma’s rights issue of MSEK 150 is fully subscribed and no issue guarantees have been used

The Board of Directors of Moberg Pharma AB (publ) (OMX: MOB) (“Moberg Pharma” or the “Company”) today announces the outcome of the fully guaranteed rights issue of units with preferential rights for Moberg Pharma’s shareholders (the “Rights Issue”) which was resolved upon by the Board of Directors on November 6[th], 2020 and approved by an extraordinary general meeting on December 1[st], 2020. In total, 16,434,319 units were subscribed for with support of unit subscription rights, corresponding to approximately 71 percent of the Rights Issue. The remaining 6,741,257 units, corresponding to

Insplorion's Nomination Committee for the 2021 Annual General Meeting has been appointed

The Nomination Committee consist of Mikael Hägg, Elin Langhammer and Fredrik Sanell. The Chairman of the Nomination Committee is Mikael Hägg, who can be reached on +46(0)727-17 17 11.In accordance with the decision of the Annual General Meeting, the company's Nomination Committee for the 2021 Annual General Meeting shall consist of three members. After the end of the third quarter, the Chairman of the Board contacted the five largest shareholders then entered in the share register and, in consultation with them, appointed three members, who shall constitute the Nomination Committee. This

Projektengagemang Sweden AB (publ) extends credit agreement

Projektengagemang Sweden AB (publ) has extended its existing agreement with SEB regarding a credit facility. The facility is extended to 27 November 2020 and consists of term loans, acquisition credit and overdraft facilities, with a total credit facility of SEK 349 million. The terms are mainly unchanged. Undrawn credit facility as of 30 September 2020 was SEK 160 million.– Along with the good results during the first nine months, the extended agreement provides financial strength and creates further stability going forward, says Peter Sandberg, CFO.  INFORMATION THAT PROJEKTENGAGEMANG

Company Announcement no. 120, 2020 - Fixing of coupons with effect as from 1 January 2021

The coupons for the FRNs listed below will change taking effect 1 January 2021. The new coupons will be in force from 1 January 2021 – 30 June 2021. FRNs without interest rate cap, CITA6, ISIN-codes:                       DK0002044395, maturity 2022, new coupon as per 1 January 2021:                     -0.16% p.a.DK0002041458, maturity 2023, new coupon as per 1 January 2021:                     -0.04% p.a. FRNs without interest rate cap, CIBOR6, ISIN-codes:DK0002038587, maturity 2021, new coupon as per 1 January 2021:                     -0.23% p.a.DK0002041532, maturity 2022,

Webstep signs framework agreement with the Norwegian Courts Administration

The agreement has a duration of four years and represents an estimated sales value of approximately NOK 100 million. The purpose of the framework agreement is to secure competence and capacity to realise the strategy of the Norwegian Courts Administration to digitise its operations.The agreement is part of a digital transformation of the case management systems in the Norwegian Courts Administration. In this process, Webstep will be responsible for the Java based applications and work as an integral part of the Norwegian Courts Administration’s IT organisation. “We are very pleased to be

Audientes implements an incentive and retention program for parts of the management and senior full-time employees

The purpose of the program is to maintain the employment of professional and valuable resources in the company, and to provide an incentive for them to make a special effort for the value creation of the company. Announcement no. 4-2020In accordance with the company’s IPO company description, the Board of Directors has today decided to implement an incentive and retention program to parts of the management and a number of full-time employees. The program consists of granting 490,000 warrants, which gives the right to a subscription of 490,000 shares in the company with an exercise price of

Catena Media repurchases bonds of a total nominal amount of EUR 2,268,000

Catena Media plc (Nasdaq Stockholm: CTM) Catena Media plc (“Catena Media” or the “Company”) today announces that the Company has repurchased bonds of its up to EUR 250,000,000 senior unsecured (and from 31 January 2021, secured) callable floating rate bonds (ISIN: SE0010832154) (the “Outstanding Bonds”), governed by the terms and conditions originally dated 2 March 2018 and as amended and restated on 29 June 2020 (the “Terms and Conditions”).Pursuant to Clause 11.2 of the Terms and Conditions (The Group Companies’ purchase of Bonds), Catena Media today announces that it has repurchased

BioStock: Ultimovacs initiates fourth phase II trial with UV1

Christmas came a few days early for Ultimovacs as the company was able to announce the initiation of its fourth phase II trial with universal vaccine UV1. The combination study, aimed at head and neck cancer patients indicated to receive checkpoint inhibitor pembrolizumab, will be conducted at 10 sites across Germany and led by renowned principal investigator Prof. Mascha Binder, M.D.Read the full article at biostock.se: https://www.biostock.se/en/ultimovacs-initiates-fourth-phase-ii-trial-with-uv1/ This is a press release from BioStock - Connecting Innovation & Capital.

Shenzhen proton therapy treatment center selects C-RAD Catalyst™ system

C-RAD has now received the purchase order from the Belgium company Ion Beam Applications SA (IBA), regarding the supply of C-RAD’s surface tracking solution for Shenzhen proton therapy center. The purchase order includes multiple Catalyst™ systems and a Sentinel™ 4DCT system including a multiyear service agreement. In June 2020 C-RAD and IBA signed a letter of Intent for the supply of the Catalyst and Sentinel systems for this project. Since June C-RAD and IBA worked on the supplier evaluation process. The successful finalization was a pre-requisite for the purchase agreement.

Penneo A/S signs first customer in Finland

Company Announcement No. 12-2020Copenhagen, December 23rd, 2020 Penneo A/S signs first audit and accounting customer, Accado, in Finland. The new contract is in alignment with the strategy to roll out Penneo's platform internationally and to focus on audit and accounting companies. Penneo A/S’s CEO Nicolaj Højer Nielsen states: “We are very happy to onboard our first Finnish customer and satisfied that it happened just two months after going live in Finland. We have already seen good traction in the Finnish market since several of our existing non-audit clients have expanded their

There are no items matching the current filter
There are no more items matching the current filter
Back to top